首页> 外文期刊>International journal of urology: official journal of the Japanese Urological Association >Detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in patients with non-gonococcal urethritis using polymerase chain reaction-microtiter plate hybridization.
【24h】

Detection of Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in patients with non-gonococcal urethritis using polymerase chain reaction-microtiter plate hybridization.

机译:使用聚合酶链反应-微量滴定板杂交检测非淋菌性尿道炎患者中的生殖支原体,人支原体,细小支原体(biovar 1)和解脲支原体(biovar 2)。

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To use polymerase chain reaction (PCR)-microtiter plate hybridization assays to detect Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma parvum (biovar 1) and Ureaplasma urealyticum (biovar 2) in first-voided urine specimens from patients with non-gonococcal urethritis (NGU). METHODS: A total of 153 male patients with NGU, who visited one of 24 clinics in Japan, were recruited for this study. All were examined using PCR-microtiter plate hybridization assays for the presence of M. genitalium, M. hominis, U. parvum (biovar 1) and U. urealyticum (biovar 2) in first-voided urine specimens. They were also examined for the presence of Chlamydia trachomatis. RESULTS: Of these 153 patients, 73 (47.7%) were positive for C. trachomatis. Overall, the prevalence was 17.0% for M. genitalium, 16.3% for U. urealyticum (biovar 2), 7.8% for U. parvum (biovar 1) and 2.6% for M. hominis. In the 80 patients with non-chlamydial NGU, the prevalence of M. genitalium, U. urealyticum (biovar 2), U. parvum (biovar 1) and M. hominis was 23.8%, 18.8%, 8.8% and 2.6%, respectively. CONCLUSIONS: This study shows the prevalence of mycoplasmas and ureaplasmas in NGU in Japan. M. genitalium and U. urealyticum (biovar 2) might be pathogens of NGU and could be associated with persistent and recurrent urethritis. When patients with NGU are treated, such pathogens should be taken into account. This PCR-microtiter plate hybridization assay provides a useful method for diagnosing NGU caused by M. genitalium and U. urealyticum (biovar 2).
机译:目的:使用聚合酶链反应(PCR)-微量滴定板杂交法检测非淋菌性尿道炎患者(第一个有尿道的尿样)中的生殖道支原体,人型支原体,细小支原体(biovar 1)和解脲支原体(biovar 2)。 NGU)。方法:本研究共招募了153名男性NGU患者,他们访问了日本24个诊所之一。使用PCR微量滴定板杂交测定法检查了所有在初次排尿的尿液中生殖器支原体,人型支原体,细支原体(生物变种1)和解脲支原体(生物变种2)的存在。他们还检查了沙眼衣原体的存在。结果:在这153例患者中,有73例(47.7%)沙眼衣原体阳性。总体而言,生殖器支原体的患病率为17.0%,解脲支原体(biovar 2)的患病率为16.3%,细支链霉菌(biovar 1)的患病率为7.8%,人型支原体的患病率为2.6%。在80例非衣原体NGU患者中,生殖器支原体,解脲支原体(biovar 2),细支原体(biovar 1)和人支原体(M.hominis)的患病率分别为23.8%,18.8%,8.8%和2.6%。 。结论:这项研究显示了日本NGU中支原体和脲原体的流行。生殖器支原体和解脲支原体(biovar 2)可能是NGU的病原体,可能与持续性尿道炎和复发性尿道炎有关。在治疗NGU患者时,应考虑此类病原体。该PCR微量滴定板杂交测定法为诊断由生殖器支原体和解脲支原体引起的NGU提供了有用的方法(biovar 2)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号